Cancer Incidence and Mortality for All Sites of Cancer, Westchester County, 2006-2010

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 2728.0 578.2 9.8 2797.4 462.6 7.8 830.2 181.2 5.6 902.4 137.7 4.1
Oral cavity and pharynx
All Oral cavity and pharynx 72.2 14.8 1.5 36.2 5.9 0.9 13.2 2.7 0.7 6.8 1.0 0.3
Lip 1.8 0.4 0.3 1.8 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0
Tongue 21.8 4.4 0.8 11.0 1.8 0.5 3.0 0.7 0.3 2.4 0.4 0.2
Salivary gland 6.8 1.5 0.5 5.2 0.9 0.3 1.0 0.2 0.2 0.8 0.1 0.1
Floor of mouth 4.2 0.9 0.4 2.2 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0
Gum & other mouth 8.8 1.8 0.5 9.4 1.5 0.4 2.0 0.4 0.3 0.4 0.1 0.1
Nasopharynx 6.4 1.3 0.5 1.6 0.3 0.2 1.2 0.2 0.2 1.6 0.3 0.2
Tonsil 14.2 2.8 0.6 2.8 0.4 0.2 1.4 0.3 0.2 0.2 0.0 0.1
Oropharynx 3.2 0.7 0.3 1.4 0.2 0.2 1.6 0.3 0.2 0.2 0.0 0.0
Hypopharynx 3.6 0.8 0.4 0.8 0.1 0.1 0.6 0.1 0.1 0.2 0.0 0.0
Other buccal cavity and pharynx 1.4 0.3 0.2 0.0 0.0 0.0 2.2 0.5 0.3 0.8 0.1 0.1
Digestive system
All Digestive system 497.4 105.2 4.2 465.4 72.5 3.0 239.2 51.2 2.9 221.2 32.7 2.0
Esophagus 35.4 7.4 1.1 15.2 2.4 0.5 31.4 6.6 1.0 12.2 1.8 0.5
Stomach 50.2 10.9 1.4 39.8 6.2 0.9 28.0 6.1 1.0 20.4 3.0 0.6
Small intestine 15.2 3.2 0.7 13.4 2.1 0.5 2.2 0.4 0.3 3.4 0.5 0.3
Colorectal 232.0 49.5 2.9 248.6 38.9 2.2 75.6 16.5 1.7 88.6 13.0 1.2
Colon excluding rectum 164.6 35.4 2.4 191.8 29.7 1.9 61.2 13.4 1.5 74.4 10.8 1.1
Cecum 30.0 6.5 1.1 44.4 6.7 0.9            
Appendix 4.2 0.8 0.4 7.0 1.2 0.4            
Ascending colon 30.8 6.7 1.1 42.0 6.5 0.9            
Hepatic flexure 8.4 1.9 0.6 11.0 1.6 0.4            
Transverse colon 12.8 2.8 0.7 17.6 2.6 0.6            
Splenic flexure 5.6 1.2 0.5 4.4 0.7 0.3            
Descending colon 11.2 2.5 0.6 8.6 1.4 0.4            
Sigmoid colon 51.8 10.9 1.3 43.6 7.0 0.9            
Large intestine, NOS 9.8 2.1 0.6 13.2 2.0 0.5            
Rectum & rectosigmoid 67.4 14.1 1.5 56.8 9.1 1.1 14.4 3.1 0.7 14.2 2.1 0.5
Rectosigmoid junction 18.0 3.8 0.8 17.4 2.8 0.6            
Rectum 49.4 10.2 1.3 39.4 6.3 0.9            
Anus, anal canal & anorectum 8.4 1.7 0.5 15.4 2.5 0.6 0.4 0.1 0.1 1.2 0.2 0.1
Liver and intrahepatic bile duct 59.4 11.9 1.4 19.6 3.1 0.6 35.4 7.3 1.1 18.0 2.8 0.6
Liver 54.0 10.8 1.3 13.6 2.2 0.5 27.4 5.5 0.9 10.0 1.6 0.4
Intrahepatic bile duct 5.4 1.2 0.4 6.0 0.9 0.3 8.0 1.8 0.6 8.0 1.2 0.4
Gallbladder 6.2 1.3 0.5 9.8 1.5 0.4 2.2 0.5 0.3 6.2 0.9 0.3
Other biliary 14.4 3.1 0.7 9.0 1.4 0.4 2.2 0.5 0.3 4.8 0.7 0.3
Pancreas 71.6 15.2 1.6 82.0 12.4 1.2 59.2 12.6 1.5 63.6 9.4 1.1
Retroperitoneum 2.0 0.4 0.3 1.8 0.3 0.2 0.4 0.1 0.1 0.2 0.0 0.1
Peritoneum, omentum & mesentery 0.6 0.1 0.1 6.0 1.0 0.4 0.4 0.1 0.1 1.8 0.2 0.2
Other digestive organs 2.0 0.4 0.3 4.8 0.8 0.3 1.8 0.4 0.3 0.8 0.1 0.1
Respiratory system
All Respiratory system 327.6 70.8 3.5 346.4 55.2 2.6 211.6 46.3 2.8 211.8 32.6 2.0
Nasal cavity, middle ear & sinuses 4.2 0.9 0.4 3.4 0.6 0.3 0.2 0.0 0.1 0.4 0.0 0.1
Larynx 28.0 5.9 1.0 7.8 1.2 0.4 6.2 1.3 0.5 2.0 0.3 0.2
Lung and bronchus 294.2 63.7 3.3 334.0 53.2 2.6 204.8 44.9 2.8 209.0 32.2 2.0
Pleura 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.1
Trachea, mediastinum, other respiratory 1.2 0.3 0.2 1.0 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.1
Soft tissue, bone, and skin
Bones & joints 6.4 1.4 0.5 4.0 0.8 0.3 1.8 0.4 0.3 0.6 0.1 0.1
Soft tissue (including heart) 20.6 4.4 0.8 17.2 3.0 0.6 4.2 0.9 0.4 7.2 1.2 0.4
Skin~ 125.0 26.6 2.1 93.4 15.9 1.5 20.0 4.4 0.9 12.6 1.9 0.5
Melanoma of the skin 118.4 25.2 2.1 86.6 14.8 1.4 15.6 3.4 0.8 10.2 1.5 0.4
Breast
Breast 7.2 1.5 0.5 836.4 141.5 4.4 1.6 0.4 0.2 136.4 21.3 1.6
Female genital system
All Female genital system       324.0 54.8 2.7       109.2 17.3 1.5
Cervix uteri       38.2 7.2 1.0       10.8 1.9 0.5
Corpus uterus and NOS       176.0 29.1 1.9       39.4 6.2 0.9
Ovary       84.8 14.4 1.4       53.4 8.4 1.0
Vagina       3.0 0.5 0.3       1.2 0.2 0.1
Vulva       13.8 2.2 0.5       3.4 0.5 0.2
Other female genital organs       8.2 1.3 0.4       1.0 0.2 0.1
Male genital system
All Male genital system 869.4 180.7 5.4       99.4 22.5 2.0      
Prostate 837.8 173.4 5.3       98.0 22.2 2.0      
Testis 27.2 6.3 1.1       0.6 0.1 0.2      
Penis 3.4 0.7 0.3       0.8 0.2 0.2      
Other male genital organs 1.0 0.2 0.2       0.0 0.0 0.0      
Urinary system
All Urinary system 296.0 63.7 3.3 133.2 20.9 1.6 52.8 11.5 1.4 28.0 4.0 0.7
Urinary bladder (including in situ) 180.4 39.3 2.6 67.2 10.3 1.1 33.2 7.4 1.1 14.4 2.0 0.5
Kidney and renal pelvis 104.4 21.9 1.9 61.2 9.9 1.1 18.0 3.8 0.8 12.4 1.8 0.5
Ureter 4.6 1.0 0.4 3.4 0.5 0.3 0.4 0.1 0.1 0.6 0.1 0.1
Other urinary organs 6.6 1.5 0.5 1.4 0.2 0.2 1.2 0.3 0.2 0.6 0.1 0.1
Eye & orbit
Eye & orbit 6.6 1.4 0.5 5.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0
Brain and central nervous system
All Brain / other nervous system (all behaviors) 82.6 17.6 1.7 110.6 19.0 1.6 28.6 6.1 1.0 22.6 3.6 0.7
Malignant brain / other nervous system 39.8 8.5 1.2 29.6 5.2 0.9 23.8 5.1 0.9 15.8 2.6 0.6
Malignant brain 36.8 7.8 1.1 27.2 4.8 0.8            
Malignant other nervous system 3.0 0.7 0.3 2.4 0.4 0.2            
Benign brain / other nervous system* 42.8 9.1 1.2 81.0 13.8 1.4 4.8 1.0 0.4 6.8 1.0 0.3
Benign brain 6.6 1.5 0.5 7.6 1.3 0.4            
Benign other nervous system 36.2 7.6 1.1 73.4 12.5 1.3            
Endocrine system
All Endocrine system 55.0 11.6 1.4 145.0 28.0 2.1 3.8 0.8 0.4 3.8 0.6 0.3
Thyroid 48.6 10.2 1.3 140.6 27.2 2.0 2.8 0.6 0.3 2.6 0.4 0.2
Other endocrine (including thymus) 6.4 1.4 0.5 4.4 0.8 0.3 1.0 0.2 0.2 1.2 0.2 0.2
Lymphomas
All Lymphomas 150.2 32.5 2.3 138.2 23.2 1.8 38.4 8.5 1.2 37.2 5.6 0.8
Hodgkin lymphoma 14.2 3.2 0.7 17.6 3.7 0.8 1.0 0.2 0.2 2.2 0.4 0.2
Non-Hodgkin lymphomas 136.0 29.3 2.2 120.6 19.4 1.6 37.4 8.3 1.2 35.0 5.2 0.8
Myeloma
All Myeloma 47.8 10.1 1.3 42.2 6.6 0.9 20.0 4.3 0.8 19.0 2.8 0.6
Leukemias
All Leukemias 98.6 21.4 1.9 78.6 12.8 1.3 43.4 9.7 1.3 35.0 5.2 0.8
Lymphocytic leukemias 61.6 13.3 1.5 39.8 6.4 0.9 15.0 3.4 0.8 9.0 1.3 0.4
Acute lymphocytic leukemia 9.6 2.2 0.6 7.2 1.5 0.5 2.2 0.5 0.3 1.6 0.3 0.2
Chronic lymphocytic leukemia 47.0 10.0 1.3 30.8 4.6 0.7 11.4 2.5 0.7 7.2 0.9 0.3
Other lymphocytic leukemias 5.0 1.1 0.4 1.8 0.3 0.2 1.4 0.3 0.3 0.2 0.0 0.1
Myeloid and monocytic leukemias 34.4 7.5 1.1 34.6 5.9 0.9 19.2 4.2 0.9 17.0 2.7 0.6
Acute myeloid leukemia 21.2 4.6 0.9 21.6 3.6 0.7 16.2 3.5 0.8 15.6 2.5 0.6
Acute monocytic leukemia 1.8 0.4 0.3 1.8 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0
Chronic myeloid leukemia 10.6 2.3 0.6 9.4 1.6 0.5 2.0 0.5 0.3 1.0 0.2 0.1
Other myeloid/monocytic leukemias 0.8 0.2 0.2 1.8 0.3 0.2 0.8 0.2 0.2 0.4 0.1 0.1
Other leukemias 2.6 0.6 0.3 4.2 0.6 0.3 9.2 2.1 0.6 9.0 1.2 0.4
Other acute leukemias 1.2 0.3 0.2 1.6 0.2 0.1 2.8 0.6 0.3 4.4 0.6 0.2
Aleukemic, subacute, leukemia NOS 1.4 0.3 0.2 2.6 0.4 0.2 6.4 1.4 0.5 4.6 0.6 0.3
Mesothelioma
Mesothelioma 6.4 1.4 0.5 4.2 0.7 0.3            
Kaposi sarcoma
Kaposi sarcoma 5.6 1.3 0.5 1.2 0.2 0.2            
Myelodysplastic syndromes
Myelodysplastic syndromes 39.4 8.8 1.2 28.0 4.2 0.7            
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 20.8 4.5 0.9 19.4 3.1 0.6            
Ill defined and unspecified sites
Ill defined and unspecified sites 36.0 7.8 1.2 49.8 7.3 0.9 57.0 12.4 1.5 57.8 8.8 1.0

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2012.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.